Keith H Nuechterlein
Overview
Explore the profile of Keith H Nuechterlein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
222
Citations
9665
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nuechterlein K, Green M, Marder S
Schizophr Bull
. 2025 Feb;
51(2):283-286.
PMID: 39982840
Given the difficulties of developing cognitive enhancers for schizophrenia and demonstrating their efficacy, we welcome a review of the measurement procedures and the clinical trial design recommendations developed through the...
2.
Forsyth J, Zhu J, Chavannes A, Trevorrow Z, Hyat M, Sievertsen S, et al.
medRxiv
. 2024 Aug;
PMID: 39211869
Schizophrenia spectrum disorders (SSDs) are characterized by substantial clinical and genetic heterogeneity. Multiple recurrent copy number variants (CNVs) increase risk for SSDs; however, how known risk CNVs and broader genome-wide...
3.
Nuechterlein K, Nasrallah H, Velligan D
Schizophr Bull
. 2024 Aug;
51(2):401-421.
PMID: 39088730
Background: Cognitive impairment associated with schizophrenia (CIAS) negatively impacts daily functioning, quality of life, and recovery, yet effective pharmacotherapies and practical assessments for clinical practice are lacking. Despite the pivotal...
4.
Filip T, Hellemann G, Ventura J, Subotnik K, Green M, Nuechterlein K, et al.
Schizophr Res
. 2024 Jun;
270:212-219.
PMID: 38924939
Background: The cognitive model of negative symptoms of schizophrenia suggests that defeatist performance beliefs (DPB), or overgeneralized negative beliefs about one's performance, are an intermediary variable along the pathway from...
5.
Guha A, Popov T, Bartholomew M, Reed A, Diehl C, Subotnik K, et al.
Psychophysiology
. 2024 Jun;
61(10):e14627.
PMID: 38924105
Individuals diagnosed with schizophrenia (SZ) demonstrate difficulty distinguishing between internally and externally generated stimuli. These aberrations in "source monitoring" have been theorized as contributing to symptoms of the disorder, including...
6.
Le T, Ventura J, Subotnik K, Nuechterlein K
Schizophr Res
. 2024 Mar;
266:249-255.
PMID: 38442522
Coordinated Specialty Care (CSC) and embedded group therapeutic interventions have been effective in improving outcomes for individuals experiencing recent first-episode schizophrenia, including cognitive performance and functioning. Treatment response varies substantially,...
7.
Ruiz-Yu B, Le T, Ventura J, Arevian A, Hellemann G, Nuechterlein K
Early Interv Psychiatry
. 2024 Feb;
18(10):805-813.
PMID: 38356325
Aim: Research has demonstrated that participation in aerobic exercise can have significant beneficial effects across both physical and mental health domains for individuals who are in the early phase of...
8.
Ventura J, Subotnik K, Han S, Hellemann G, Green M, Nuechterlein K
Psychol Med
. 2024 Feb;
53(14):6878-6887.
PMID: 38314778
Background: Studies that examined sex differences in first-episode patients consistently show that males compared to females have poor premorbid adjustment, earlier age of onset, worse clinical characteristics, and poorer outcomes....
9.
Abplanalp S, Braff D, Light G, Joshi Y, Nuechterlein K, Green M
Psychol Med
. 2024 Jan;
54(9):1930-1939.
PMID: 38287656
Background: Research using latent variable models demonstrates that pre-attentive measures of early auditory processing (EAP) and cognition may initiate a cascading effect on daily functioning in schizophrenia. However, such models...
10.
Joshi Y, Molina J, Braff D, Green M, Gur R, Gur R, et al.
Am J Psychiatry
. 2023 Apr;
180(7):519-523.
PMID: 37038743
No abstract available.